International Conference on Lupus and Autoimmune Disorders
(ICLAAD-26)

28th November 2026 || Visakhapatnam - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Lupus and Autoimmune Disorders (ICLAAD), scheduled to be held on 28th November 2026 in Visakhapatnam, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Rheumatology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Lupus Diagnostics
    This track will explore the latest innovations in molecular diagnostics for lupus and related autoimmune disorders. Emphasis will be placed on the identification and validation of novel biomarkers that enhance diagnostic accuracy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Translational Research in Autoimmunity
    This session will focus on the bridge between laboratory discoveries and clinical applications in the field of autoimmune diseases. Presentations will highlight successful translational research initiatives that have led to improved patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Therapeutic Strategies for Lupus Management
    This track will examine emerging therapeutic strategies and treatment modalities for managing lupus and its complications. Discussions will include both pharmacological and non-pharmacological approaches to patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 04 – Immunological Mechanisms in Autoimmune Disorders
    This session will delve into the underlying immunological mechanisms that drive lupus and other autoimmune conditions. Research findings will be presented that elucidate the role of immune dysregulation in disease pathogenesis. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Clinical Research Methodologies in Rheumatology
    This track will address innovative clinical research methodologies tailored for rheumatology studies. Emphasis will be placed on the design, implementation, and analysis of clinical trials in lupus and autoimmune disorders. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Patient-Centered Care in Autoimmune Disorders
    This session will focus on the importance of patient-centered approaches in the management of lupus and autoimmune diseases. Presentations will highlight strategies for enhancing patient engagement and improving quality of care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 07 – Laboratory Innovations in Rheumatology
    This track will showcase cutting-edge laboratory techniques and technologies that are transforming the field of rheumatology. Topics will include advancements in diagnostic tools and research methodologies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Biomarker Discovery in Autoimmune Diseases
    This session will explore the latest findings in biomarker discovery for lupus and related autoimmune disorders. Researchers will present their work on identifying potential biomarkers for disease diagnosis and monitoring. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Epidemiology and Risk Factors of Lupus
    This track will investigate the epidemiological aspects and risk factors associated with lupus and autoimmune disorders. Discussions will include population-based studies and their implications for public health. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Psychosocial Aspects of Autoimmune Disorders
    This session will examine the psychosocial impact of lupus and autoimmune diseases on patients and their families. Research will focus on mental health, coping strategies, and support systems. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Future Directions in Rheumatology Research
    This track will provide insights into future research directions and emerging trends in the field of rheumatology. Participants will discuss potential breakthroughs and the implications for clinical practice. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228